References
[1] Patent: CN107488175, 2017, A. Location in patent: Paragraph 0008; 0010
[2] Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1982, vol. 36, # 1 B, p. 15 - 18
[3]
Rej, R. K., Wang, C., Lu, J., Wang, M., Petrunak, E., Zawacki, K. P., McEachern, D., Yang, C.-Y., Wang, L., Li, R., Chinnaswamy, K., Wen, B., Sun, D., Stuckey, J. A., Zhou, Y., Chen, J., Tang, G., Wang, S. (2021). Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression. Journal of Medicinal Chemistry, 64(19), 14540–14556.
https://doi.org/10.1021/acs.jmedchem.1c01059 [4]
Zhang, W., Zhang, D., Stashko, M. A., DeRyckere, D., Hunter, D., Kireev, D., Miley, M. J., Cummings, C., Lee, M., Norris-Drouin, J., Stewart, W. M., Sather, S., Zhou, Y., Kirkpatrick, G., Machius, M., Janzen, W. P., Earp, H. S., Graham, D. K., Frye, S. V., Wang, X. (2013). Pseudo-Cyclization through Intramolecular Hydrogen Bond Enables Discovery of Pyridine Substituted Pyrimidines as New Mer Kinase Inhibitors. Journal of Medicinal Chemistry, 56(23), 9683–9692.
https://doi.org/10.1021/jm401387j